High levels of TRAF4 promote intrahepatic cholangiocarcinoma (ICC) cell invasiveness by activating AKT signaling, and TRAF4 overexpression is associated with shorter overall survival and higher recurrence rates in ICC patients (63). The gene discussed is AKT1; the disease is intrahepatic cholangiocarcinoma.